| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
36,352 |
34,347 |
$9.55M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,815 |
28,100 |
$5.07M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
27,455 |
25,093 |
$1.53M |
| 64450 |
|
2,111 |
934 |
$1.24M |
| 20553 |
|
4,622 |
3,003 |
$713K |
| 99152 |
|
11,724 |
8,342 |
$534K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,315 |
2,021 |
$521K |
| 99233 |
Prolong inpt eval add15 m |
5,779 |
1,041 |
$394K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,074 |
14,375 |
$380K |
| 64405 |
|
1,277 |
790 |
$372K |
| G0378 |
Hospital observation service, per hour |
1,732 |
824 |
$323K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,277 |
2,412 |
$305K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,368 |
3,657 |
$250K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,474 |
9,030 |
$244K |
| 36415 |
Collection of venous blood by venipuncture |
14,535 |
12,012 |
$238K |
| 64400 |
|
175 |
102 |
$217K |
| H2012 |
Behavioral health day treatment, per hour |
1,485 |
182 |
$202K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,086 |
1,048 |
$197K |
| Q3014 |
Telehealth originating site facility fee |
6,591 |
5,871 |
$188K |
| 80053 |
Comprehensive metabolic panel |
5,542 |
4,989 |
$178K |
| 85027 |
|
13,887 |
12,780 |
$166K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,570 |
736 |
$164K |
| 99223 |
Prolong inpt eval add15 m |
1,169 |
914 |
$157K |
| 76818 |
|
795 |
555 |
$127K |
| 70450 |
Computed tomography, head or brain; without contrast material |
753 |
686 |
$122K |
| 64520 |
|
182 |
98 |
$111K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
88 |
85 |
$106K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,221 |
1,958 |
$105K |
| 90870 |
|
430 |
148 |
$99K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
810 |
790 |
$81K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,424 |
11,453 |
$81K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
12,520 |
9,210 |
$80K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,759 |
1,621 |
$78K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
512 |
460 |
$76K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
10,197 |
7,207 |
$72K |
| 77003 |
|
950 |
509 |
$69K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,415 |
970 |
$67K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
11,439 |
7,831 |
$64K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,574 |
1,448 |
$63K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
236 |
164 |
$61K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
780 |
738 |
$57K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
376 |
344 |
$56K |
| 71046 |
Radiologic examination, chest; 2 views |
1,921 |
1,752 |
$55K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,743 |
1,361 |
$45K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
321 |
133 |
$44K |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,005 |
2,505 |
$36K |
| 99222 |
Initial hospital care, per day, moderate complexity |
388 |
306 |
$35K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
530 |
220 |
$33K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
259 |
220 |
$32K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,436 |
1,324 |
$32K |
| 99220 |
|
229 |
220 |
$28K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
347 |
238 |
$28K |
| J2704 |
Injection, propofol, 10 mg |
7,197 |
4,679 |
$27K |
| 59025 |
Fetal non-stress test |
513 |
362 |
$26K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
63 |
51 |
$26K |
| 97810 |
|
1,730 |
952 |
$25K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
239 |
235 |
$21K |
| 64615 |
|
78 |
75 |
$21K |
| 99254 |
|
187 |
157 |
$21K |
| 99226 |
|
259 |
133 |
$18K |
| 90791 |
Psychiatric diagnostic evaluation |
348 |
339 |
$17K |
| 71045 |
Radiologic examination, chest; single view |
513 |
479 |
$17K |
| 81001 |
|
2,036 |
1,823 |
$16K |
| 99153 |
Mod sedat endo service >5yrs |
1,081 |
645 |
$14K |
| 84484 |
|
3,712 |
2,458 |
$13K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
123 |
104 |
$13K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,613 |
3,815 |
$11K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
227 |
220 |
$11K |
| 99460 |
|
139 |
138 |
$10K |
| 99217 |
|
201 |
194 |
$10K |
| 82565 |
|
811 |
622 |
$10K |
| 99221 |
|
144 |
129 |
$10K |
| 97597 |
|
120 |
81 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,932 |
2,234 |
$8K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
308 |
150 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
851 |
831 |
$8K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
43 |
25 |
$7K |
| 99253 |
|
99 |
89 |
$7K |
| 99255 |
|
54 |
48 |
$7K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,694 |
1,420 |
$7K |
| 97811 |
|
1,727 |
951 |
$7K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
5,757 |
4,303 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
189 |
173 |
$6K |
| 90901 |
|
210 |
129 |
$6K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
59 |
54 |
$6K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
93 |
85 |
$6K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,891 |
2,158 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
74 |
27 |
$6K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
279 |
109 |
$6K |
| 62323 |
|
13 |
13 |
$6K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
268 |
258 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,660 |
1,423 |
$5K |
| 83690 |
|
1,433 |
1,273 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
189 |
173 |
$5K |
| 76820 |
|
77 |
66 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
71 |
50 |
$4K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
756 |
497 |
$4K |
| 82248 |
|
1,223 |
1,111 |
$4K |
| 59514 |
|
39 |
33 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
450 |
433 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
190 |
183 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
44 |
43 |
$4K |
| 99225 |
|
90 |
45 |
$4K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
224 |
126 |
$4K |
| 85610 |
|
1,314 |
1,037 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,443 |
1,210 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
889 |
395 |
$3K |
| 81514 |
|
12 |
12 |
$3K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
13 |
12 |
$3K |
| 85018 |
|
777 |
606 |
$3K |
| 96376 |
|
220 |
111 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,357 |
3,473 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
27 |
26 |
$3K |
| 83880 |
|
299 |
275 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,299 |
1,096 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
98 |
90 |
$3K |
| 0240U |
|
26 |
26 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
268 |
248 |
$2K |
| 87481 |
|
79 |
74 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
79 |
74 |
$2K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
43 |
42 |
$2K |
| 76825 |
|
15 |
14 |
$2K |
| 81025 |
|
356 |
328 |
$2K |
| 83735 |
|
735 |
497 |
$2K |
| 80061 |
Lipid panel |
123 |
119 |
$2K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
24 |
24 |
$2K |
| 86803 |
|
128 |
124 |
$2K |
| 93226 |
|
27 |
24 |
$2K |
| 81003 |
|
292 |
272 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
13 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
70 |
31 |
$2K |
| 86780 |
|
79 |
74 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
15 |
15 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
21 |
12 |
$1K |
| 93227 |
|
74 |
73 |
$1K |
| 93016 |
|
59 |
57 |
$931.69 |
| 93325 |
|
84 |
79 |
$873.09 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
379 |
283 |
$872.59 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
13 |
13 |
$742.50 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
14 |
13 |
$703.22 |
| 93018 |
|
64 |
62 |
$660.39 |
| 76937 |
|
27 |
26 |
$634.91 |
| 99462 |
|
19 |
13 |
$609.71 |
| C1769 |
Guide wire |
138 |
118 |
$516.97 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
48 |
26 |
$508.97 |
| 83605 |
|
158 |
113 |
$460.84 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$442.54 |
| 97161 |
|
27 |
24 |
$424.96 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
58 |
58 |
$340.02 |
| 93228 |
|
15 |
15 |
$323.40 |
| 84703 |
|
58 |
57 |
$308.86 |
| 85379 |
|
28 |
26 |
$307.10 |
| 82077 |
|
56 |
51 |
$299.03 |
| 93321 |
|
57 |
52 |
$294.41 |
| 84145 |
|
16 |
16 |
$264.88 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
14 |
$259.54 |
| 84132 |
|
115 |
67 |
$220.19 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
103 |
64 |
$218.57 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
80 |
61 |
$216.20 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
36 |
27 |
$167.04 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
42 |
38 |
$140.41 |
| 95874 |
|
40 |
37 |
$125.71 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
49 |
26 |
$125.56 |
| 94060 |
|
14 |
14 |
$110.31 |
| 94729 |
|
15 |
15 |
$101.34 |
| J1644 |
Injection, heparin sodium, per 1000 units |
25 |
12 |
$90.52 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
126 |
50 |
$70.73 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
69 |
43 |
$68.80 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
38 |
34 |
$47.07 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
56 |
49 |
$20.95 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
15 |
14 |
$11.85 |
| A9270 |
Non-covered item or service |
1,987 |
1,067 |
$2.34 |